{"ID": "DDI-DrugBank.d638.s2.p38", "TEXT1": "N/A N/A N/A have N/A that N/A may N/A the N/A of N/A N/A N/A (phenobarbital @DRUG$ primidone) N/A and tricyclic N/A (imipramine @DRUG$ desipramine)", "LBL": "0", "DRUGA": ["diphenylhydantoin", "drug", "139-155"], "DRUGB": ["clomipramine", "drug", "219-230"]}
{"ID": "DDI-DrugBank.d694.s0.p2", "TEXT1": "Digoxin: There was a N/A N/A in the N/A under the N/A (AUC 11%) and N/A N/A N/A N/A (Cmax 18%) of @DRUG$ with the N/A administration of 100 mg @DRUG$ for N/A N/A", "LBL": "DDI-mechanism", "DRUGA": ["digoxin", "drug", "124-130"], "DRUGB": ["sitagliptin", "drug", "169-179"]}
{"ID": "DDI-DrugBank.d776.s23.p0", "TEXT1": "The N/A N/A N/A @DRUG$ at doses N/A N/A mg or N/A with @DRUG$ is N/A", "LBL": "DDI-advise", "DRUGA": ["fluconazole", "drug", "20-30"], "DRUGB": ["terfenadine", "drug", "67-77"]}
{"ID": "DDI-DrugBank.d576.s6.p5", "TEXT1": "@DRUG$ competes with a N/A of N/A for N/A N/A N/A notably N/A N/A N/A N/A N/A @DRUG$ N/A N/A N/A and N/A N/A", "LBL": "DDI-mechanism", "DRUGA": ["Salicylate", "group", "0-9"], "DRUGB": ["sulfinpyrazone", "drug", "142-155"]}
{"ID": "DDI-DrugBank.d769.s1.p0", "TEXT1": "N/A should carefully N/A N/A and N/A in N/A concurrently N/A @DRUG$ and @DRUG$", "LBL": "DDI-advise", "DRUGA": ["ZOLINZA", "brand", "85-91"], "DRUGB": ["coumarin derivatives", "group", "97-116"]}
{"ID": "DDI-DrugBank.d655.s0.p17", "TEXT1": "@DRUG$ may interact with N/A (tricyclic type) N/A N/A (e g N/A N/A N/A N/A N/A furazolidone) N/A N/A N/A (e g diphenhydramine) other N/A N/A N/A N/A N/A N/A N/A anti diarrhea N/A (e g @DRUG$ pectin) N/A (e g N/A promethazine)", "LBL": "DDI-int", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["kaolin", "drug", "347-352"]}
{"ID": "DDI-DrugBank.d618.s1.p4", "TEXT1": "N/A N/A N/A N/A N/A N/A @DRUG$ and N/A N/A N/A N/A that N/A N/A N/A (such as N/A N/A and abciximab) may N/A the risk of N/A if N/A prior N/A or after @DRUG$ N/A", "LBL": "DDI-effect", "DRUGA": ["heparin", "drug", "40-46"], "DRUGB": ["Retavase", "brand", "225-232"]}
{"ID": "DDI-MedLine.d143.s3.p0", "TEXT1": "N/A N/A N/A @DRUG$ and @DRUG$ was N/A N/A N/A the N/A (AUC) N/A N/A N/A N/A by 50% and N/A sharply N/A N/A N/A as a N/A N/A N/A by N/A N/A N/A a N/A N/A (CYP) N/A", "LBL": "DDI-mechanism", "DRUGA": ["omeprazole", "drug", "19-28"], "DRUGB": ["clopidogrel", "drug", "34-44"]}
{"ID": "DDI-DrugBank.d780.s4.p2", "TEXT1": "CNS depressant medications: N/A N/A N/A @DRUG$ and @DRUG$ may N/A in N/A depressant N/A", "LBL": "DDI-effect", "DRUGA": ["procaine hydrochloride", "drug", "46-67"], "DRUGB": ["CNS depressant medications", "group", "73-98"]}
{"ID": "DDI-DrugBank.d761.s0.p11", "TEXT1": "Alcohol: In a N/A N/A study in N/A N/A N/A subjects N/A of N/A and N/A N/A of @DRUG$ (e g N/A 3 N/A of wine) did N/A N/A in N/A of N/A N/A N/A N/A (fecal N/A excretion) or N/A N/A N/A @DRUG$", "LBL": "0", "DRUGA": ["alcohol", "drug", "108-114"], "DRUGB": ["orlistat", "drug", "287-294"]}
{"ID": "DDI-DrugBank.d776.s20.p2", "TEXT1": "Terfenadine: Because of the N/A of N/A N/A N/A N/A N/A N/A of the N/A N/A in N/A N/A @DRUG$ in N/A with @DRUG$ N/A N/A have been N/A", "LBL": "DDI-effect", "DRUGA": ["azole antifungals", "group", "139-155"], "DRUGB": ["terfenadine", "drug", "177-187"]}
{"ID": "DDI-DrugBank.d643.s0.p12", "TEXT1": "@DRUG$ may interact with the N/A drugs: N/A and other N/A (may N/A N/A levels) N/A (bioavailability of N/A N/A is N/A with coadministration) N/A N/A (may N/A N/A levels) N/A (reports of N/A episodes when coadministered) N/A (coadministration of N/A with N/A can N/A N/A N/A in women) benzodiazepenes and other N/A N/A (may N/A in N/A N/A and an N/A N/A of adverse effects) and @DRUG$ (coadministration of N/A and N/A may N/A with the N/A of the corticosteroids)", "LBL": "DDI-int", "DRUGA": ["Melatonin", "drug", "0-8"], "DRUGB": ["corticosteroids", "group", "521-535"]}
{"ID": "DDI-DrugBank.d643.s0.p8", "TEXT1": "@DRUG$ may interact with the N/A drugs: N/A and other N/A (may N/A N/A levels) N/A (bioavailability of N/A N/A is N/A with coadministration) N/A N/A (may N/A N/A levels) N/A (reports of N/A episodes when coadministered) @DRUG$ (coadministration of N/A with N/A can N/A N/A N/A in women) benzodiazepenes and other N/A N/A (may N/A in N/A N/A and an N/A N/A of adverse effects) and N/A (coadministration of N/A and N/A may N/A with the N/A of the corticosteroids)", "LBL": "DDI-int", "DRUGA": ["Melatonin", "drug", "0-8"], "DRUGB": ["progestin", "group", "299-307"]}
{"ID": "DDI-MedLine.d194.s9.p0", "TEXT1": "HEY N/A N/A N/A @DRUG$ N/A @DRUG$ N/A N/A N/A than did N/A N/A N/A either N/A N/A", "LBL": "DDI-effect", "DRUGA": ["dasatinib", "drug", "23-31"], "DRUGB": ["paclitaxel", "drug", "38-47"]}
{"ID": "DDI-DrugBank.d737.s10.p44", "TEXT1": "Dopamine antagonists: Since N/A is a N/A N/A it is N/A that N/A antagonists such as the N/A (phenothiazines N/A thioxanthenes) or @DRUG$ may N/A the N/A of @DRUG$", "LBL": "DDI-effect", "DRUGA": ["metoclopramide", "group", "181-194"], "DRUGB": ["MIRAPEX", "brand", "231-237"]}
{"ID": "DDI-DrugBank.d776.s2.p14", "TEXT1": "These are N/A in N/A N/A below: Oral hypoglycemics @DRUG$ @DRUG$ N/A N/A N/A N/A N/A N/A N/A N/A Short acting benzodiazepines Oral hypoglycemics: Clinically N/A N/A may be N/A by the N/A N/A N/A with oral hypoglycemic agents;", "LBL": "0", "DRUGA": ["Coumarin-type anticoagulants", "group", "66-93"], "DRUGB": ["Phenytoin", "drug", "96-104"]}
{"ID": "DDI-DrugBank.d655.s0.p15", "TEXT1": "@DRUG$ may interact with N/A (tricyclic type) N/A N/A (e g N/A N/A N/A N/A N/A furazolidone) N/A N/A N/A (e g diphenhydramine) other N/A N/A N/A N/A @DRUG$ N/A N/A anti diarrhea N/A (e g kaolin pectin) N/A (e g N/A promethazine)", "LBL": "DDI-int", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["antacids", "group", "291-298"]}
{"ID": "DDI-DrugBank.d752.s1.p17", "TEXT1": "N/A such as erythromycin N/A N/A @DRUG$ N/A and N/A were N/A N/A significantly N/A the N/A N/A and N/A of N/A N/A @DRUG$", "LBL": "DDI-mechanism", "DRUGA": ["ketoconazole", "drug", "50-61"], "DRUGB": ["midazolam", "drug", "171-179"]}
{"ID": "DDI-DrugBank.d777.s1.p10", "TEXT1": "N/A N/A Anticoagulants and Antiplatelet Agents @DRUG$ N/A N/A or in N/A with @DRUG$ and N/A may N/A N/A N/A", "LBL": "DDI-effect", "DRUGA": ["Streptase", "brand", "49-57"], "DRUGB": ["antiplatelet agents", "group", "104-122"]}
{"ID": "DDI-DrugBank.d737.s6.p6", "TEXT1": "Other N/A N/A via N/A secretion: Population N/A analysis N/A that N/A of N/A that are N/A by the N/A N/A N/A (e g @DRUG$ N/A N/A N/A N/A N/A and quinine) N/A the N/A N/A of @DRUG$ by N/A 20% while those N/A by the anionic N/A N/A (e g N/A N/A N/A N/A and chlorpropamide) are N/A N/A have N/A N/A on the N/A N/A of N/A", "LBL": "DDI-mechanism", "DRUGA": ["cimetidine", "drug", "178-187"], "DRUGB": ["pramipexole", "drug", "293-303"]}
{"ID": "DDI-DrugBank.d610.s3.p0", "TEXT1": "@DRUG$ N/A the N/A of @DRUG$ N/A an N/A in N/A N/A The N/A of N/A has N/A clinically N/A N/A on the N/A N/A of N/A", "LBL": "DDI-mechanism", "DRUGA": ["Ethanol", "drug", "0-6"], "DRUGB": ["abacavir", "drug", "37-44"]}
{"ID": "DDI-DrugBank.d601.s0.p1", "TEXT1": "@DRUG$ may N/A the N/A of N/A N/A N/A @DRUG$ N/A N/A N/A N/A and N/A N/A", "LBL": "DDI-int", "DRUGA": ["Barbiturates", "group", "0-11"], "DRUGB": ["antibiotics", "group", "76-86"]}
{"ID": "DDI-DrugBank.d579.s1.p0", "TEXT1": "The N/A of @DRUG$ may be potentiated by N/A other @DRUG$ and N/A", "LBL": "DDI-effect", "DRUGA": ["Mecamylamine", "drug", "14-25"], "DRUGB": ["antihypertensive drugs", "group", "67-88"]}
{"ID": "DDI-DrugBank.d775.s10.p13", "TEXT1": "Other N/A which may N/A the neuromuscular blocking N/A of @DRUG$ such as N/A N/A N/A N/A (e g N/A N/A N/A N/A N/A N/A N/A and N/A colistimethate) N/A N/A N/A N/A N/A @DRUG$ and N/A", "LBL": "DDI-int", "DRUGA": ["nondepolarizing agents", "drug", "67-88"], "DRUGB": ["procainamide", "drug", "306-317"]}
{"ID": "DDI-DrugBank.d573.s1.p0", "TEXT1": "If at all N/A @DRUG$ should be N/A N/A before @DRUG$ is N/A", "LBL": "DDI-advise", "DRUGA": ["guanethidine", "drug", "19-30"], "DRUGB": ["minoxidil", "drug", "67-75"]}
{"ID": "DDI-DrugBank.d709.s4.p8", "TEXT1": "Cisapride pimozide: Other N/A such as @DRUG$ or N/A which are metabolised by N/A N/A N/A have been N/A N/A N/A N/A N/A and/or N/A N/A (typically torsades de pointe) as a N/A of N/A in their N/A N/A N/A to N/A N/A N/A N/A of the isozyme N/A some @DRUG$", "LBL": "DDI-mechanism", "DRUGA": ["cisapride", "drug", "43-51"], "DRUGB": ["macrolide antibacterials", "group", "352-375"]}
{"ID": "DDI-DrugBank.d743.s4.p0", "TEXT1": "N/A N/A of @DRUG$ and @DRUG$ is N/A", "LBL": "DDI-advise", "DRUGA": ["ketoconazole", "drug", "30-41"], "DRUGB": ["terfenadine", "drug", "47-57"]}
{"ID": "DDI-DrugBank.d652.s1.p2", "TEXT1": "N/A N/A N/A can N/A when @DRUG$ is N/A with N/A N/A @DRUG$ N/A or N/A", "LBL": "DDI-effect", "DRUGA": ["metoclopramide", "drug", "41-54"], "DRUGB": ["hypnotics", "group", "90-98"]}
{"ID": "DDI-DrugBank.d643.s0.p0", "TEXT1": "@DRUG$ may interact with the N/A drugs: @DRUG$ and other N/A (may N/A N/A levels) N/A (bioavailability of N/A N/A is N/A with coadministration) N/A N/A (may N/A N/A levels) N/A (reports of N/A episodes when coadministered) N/A (coadministration of N/A with N/A can N/A N/A N/A in women) benzodiazepenes and other N/A N/A (may N/A in N/A N/A and an N/A N/A of adverse effects) and N/A (coadministration of N/A and N/A may N/A with the N/A of the corticosteroids)", "LBL": "DDI-int", "DRUGA": ["Melatonin", "drug", "0-8"], "DRUGB": ["aspirin", "brand", "49-55"]}
{"ID": "DDI-DrugBank.d655.s0.p6", "TEXT1": "@DRUG$ may interact with N/A (tricyclic type) N/A N/A (e g N/A N/A N/A @DRUG$ N/A furazolidone) N/A N/A N/A (e g diphenhydramine) other N/A N/A N/A N/A N/A N/A N/A anti diarrhea N/A (e g kaolin pectin) N/A (e g N/A promethazine)", "LBL": "DDI-int", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["isocarboxazid", "drug", "130-142"]}
{"ID": "DDI-DrugBank.d766.s2.p0", "TEXT1": "N/A N/A N/A N/A N/A N/A N/A has N/A that @DRUG$ N/A a N/A N/A in @DRUG$ N/A and that N/A N/A the N/A N/A N/A N/A N/A N/A by competing for N/A N/A", "LBL": "DDI-mechanism", "DRUGA": ["cimetidine", "drug", "56-65"], "DRUGB": ["trimetrexate", "drug", "101-112"]}
{"ID": "DDI-DrugBank.d726.s1.p60", "TEXT1": "A N/A dose drug drug interaction N/A demonstrated that N/A N/A N/A N/A AUC0 Since N/A is partially N/A by N/A and N/A N/A is N/A N/A be a N/A N/A of N/A N/A N/A N/A N/A should be N/A while N/A @DRUG$ with N/A and other N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A @DRUG$ N/A N/A N/A or N/A", "LBL": "DDI-advise", "DRUGA": ["paricalcitol", "drug", "291-302"], "DRUGB": ["nelfinavir", "drug", "433-442"]}
{"ID": "DDI-DrugBank.d639.s0.p8", "TEXT1": "Co administration of @DRUG$ with N/A N/A of the N/A N/A (e g N/A N/A N/A N/A N/A N/A N/A N/A @DRUG$ N/A voriconizole) may N/A N/A N/A", "LBL": "DDI-mechanism", "DRUGA": ["SUTENT", "brand", "21-26"], "DRUGB": ["saquinavir", "drug", "181-190"]}
{"ID": "DDI-MedLine.d181.s4.p0", "TEXT1": "The N/A N/A the N/A of an N/A with N/A N/A N/A on @DRUG$ who N/A a N/A N/A N/A with @DRUG$", "LBL": "DDI-int", "DRUGA": ["levothyroxine", "drug", "85-97"], "DRUGB": ["simeticone", "drug", "148-157"]}
{"ID": "DDI-DrugBank.d766.s3.p9", "TEXT1": "N/A on an N/A N/A N/A N/A N/A N/A substituted N/A N/A (clotrimazole N/A @DRUG$) were N/A N/A N/A N/A of @DRUG$ N/A", "LBL": "DDI-mechanism", "DRUGA": ["miconazole", "drug", "104-113"], "DRUGB": ["trimetrexate", "drug", "159-170"]}
{"ID": "DDI-DrugBank.d648.s6.p0", "TEXT1": "Caution should be N/A when @DRUG$ is coadministered with other N/A N/A N/A N/A such as @DRUG$ N/A N/A N/A N/A and N/A", "LBL": "DDI-advise", "DRUGA": ["EVISTA", "brand", "28-33"], "DRUGB": ["clofibrate", "drug", "100-109"]}
{"ID": "DDI-DrugBank.d655.s0.p69", "TEXT1": "N/A may interact with N/A (tricyclic type) @DRUG$ (e g N/A N/A N/A N/A N/A furazolidone) @DRUG$ N/A N/A (e g diphenhydramine) other N/A N/A N/A N/A N/A N/A N/A anti diarrhea N/A (e g kaolin pectin) N/A (e g N/A promethazine)", "LBL": "0", "DRUGA": ["MAO inhibitors", "group", "68-81"], "DRUGB": ["quinidine", "drug", "172-180"]}
{"ID": "DDI-DrugBank.d752.s10.p43", "TEXT1": "The N/A N/A of N/A N/A is N/A by any concomitantly N/A N/A which depresses the N/A N/A N/A particularly N/A (eg N/A N/A and fentanyl) N/A N/A @DRUG$ N/A and @DRUG$", "LBL": "0", "DRUGA": ["nitrous oxide", "drug", "224-236"], "DRUGB": ["droperidol", "drug", "256-265"]}
{"ID": "DDI-DrugBank.d717.s0.p0", "TEXT1": "@DRUG$ has been N/A N/A N/A the N/A of @DRUG$ by the N/A of N/A N/A N/A N/A N/A N/A an N/A in N/A N/A for N/A", "LBL": "DDI-mechanism", "DRUGA": ["Mitotane", "drug", "0-7"], "DRUGB": ["warfarin", "drug", "59-66"]}
{"ID": "DDI-DrugBank.d572.s24.p4", "TEXT1": "N/A N/A N/A of N/A N/A in N/A with @DRUG$ (statins) in N/A and N/A during N/A N/A in N/A @DRUG$ and statin N/A", "LBL": "0", "DRUGA": ["HMG-CoA reductase inhibitors", "group", "61-88"], "DRUGB": ["ezetimibe", "drug", "158-166"]}
{"ID": "DDI-DrugBank.d775.s10.p2", "TEXT1": "Other N/A which may N/A the neuromuscular blocking N/A of @DRUG$ such as N/A N/A N/A N/A (e g @DRUG$ N/A N/A N/A N/A N/A N/A and N/A colistimethate) N/A N/A N/A N/A N/A N/A and N/A", "LBL": "DDI-int", "DRUGA": ["nondepolarizing agents", "drug", "67-88"], "DRUGB": ["aminoglycosides", "group", "142-156"]}
{"ID": "DDI-DrugBank.d775.s13.p72", "TEXT1": "Some N/A N/A are: N/A N/A N/A N/A N/A for N/A or high blood pressure N/A for N/A N/A N/A N/A N/A such as N/A or N/A N/A N/A N/A by N/A N/A N/A N/A @DRUG$ or N/A N/A N/A such as @DRUG$ N/A N/A N/A or other N/A N/A", "LBL": "0", "DRUGA": ["polymyxin B", "drug", "286-296"], "DRUGB": ["procaine", "drug", "340-347"]}
{"ID": "DDI-DrugBank.d639.s0.p10", "TEXT1": "Co administration of @DRUG$ with N/A N/A of the N/A N/A (e g N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A @DRUG$) may N/A N/A N/A", "LBL": "DDI-mechanism", "DRUGA": ["SUTENT", "brand", "21-26"], "DRUGB": ["voriconizole", "drug", "208-219"]}
{"ID": "DDI-MedLine.d147.s0.p0", "TEXT1": "N/A of @DRUG$ and @DRUG$ N/A N/A and N/A vivo N/A human A375 N/A cells", "LBL": "0", "DRUGA": ["dacarbazine", "drug", "15-25"], "DRUGB": ["imexon", "drug_n", "31-36"]}
{"ID": "DDI-DrugBank.d668.s0.p9", "TEXT1": "Although N/A N/A or N/A N/A with N/A have N/A been N/A N/A the N/A of this N/A s N/A by N/A 3A4 it is N/A that N/A N/A @DRUG$ and N/A N/A may N/A its N/A (increasing N/A N/A of @DRUG$)", "LBL": "DDI-mechanism", "DRUGA": ["erythromycin", "drug", "186-197"], "DRUGB": ["mifepristone", "drug", "276-287"]}
{"ID": "DDI-DrugBank.d655.s0.p20", "TEXT1": "@DRUG$ may interact with N/A (tricyclic type) N/A N/A (e g N/A N/A N/A N/A N/A furazolidone) N/A N/A N/A (e g diphenhydramine) other N/A N/A N/A N/A N/A N/A N/A anti diarrhea N/A (e g kaolin pectin) N/A (e g @DRUG$ promethazine)", "LBL": "DDI-int", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["chlorpromazine", "drug", "385-398"]}
{"ID": "DDI-DrugBank.d611.s1.p0", "TEXT1": "@DRUG$ should be N/A with caution to N/A being treated with @DRUG$ or N/A N/A since the N/A of N/A N/A N/A on the N/A N/A may be potentiated", "LBL": "DDI-advise", "DRUGA": ["Beta adrenergic agonists", "group", "0-23"], "DRUGB": ["monoamine oxidase inhibitors", "group", "92-119"]}
{"ID": "DDI-DrugBank.d765.s1.p34", "TEXT1": "For N/A N/A N/A or other N/A N/A N/A such as other N/A N/A (eg N/A miconazole) or @DRUG$ (eg N/A clarithromycin) or N/A or N/A the N/A N/A of @DRUG$ is N/A N/A N/A", "LBL": "DDI-advise", "DRUGA": ["macrolide antibiotics", "group", "136-156"], "DRUGB": ["DETROL LA", "brand", "249-257"]}
{"ID": "DDI-DrugBank.d636.s3.p4", "TEXT1": "@DRUG$ may also N/A the N/A N/A other N/A which N/A some N/A N/A N/A N/A N/A N/A N/A N/A N/A anti infective N/A N/A and @DRUG$ Please note that N/A may interact with other N/A that are N/A N/A here", "LBL": "DDI-effect", "DRUGA": ["Mephenytoin", "drug", "0-10"], "DRUGB": ["theophylline", "drug", "193-204"]}
{"ID": "DDI-DrugBank.d608.s5.p3", "TEXT1": "N/A and other @DRUG$ have been N/A N/A reduce the N/A N/A of @DRUG$ in an N/A N/A N/A N/A the N/A of N/A", "LBL": "DDI-mechanism", "DRUGA": ["nonsteroidal anti-inflammatory drugs", "group", "19-54"], "DRUGB": ["methotrexate", "drug", "110-121"]}
{"ID": "DDI-DrugBank.d655.s0.p2", "TEXT1": "@DRUG$ may interact with N/A (tricyclic type) @DRUG$ (e g N/A N/A N/A N/A N/A furazolidone) N/A N/A N/A (e g diphenhydramine) other N/A N/A N/A N/A N/A N/A N/A anti diarrhea N/A (e g kaolin pectin) N/A (e g N/A promethazine)", "LBL": "DDI-int", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["MAO inhibitors", "group", "68-81"]}
{"ID": "DDI-DrugBank.d653.s5.p2", "TEXT1": "This could N/A to N/A N/A N/A N/A or N/A the N/A of @DRUG$ toxicity when @DRUG$ is N/A", "LBL": "DDI-effect", "DRUGA": ["salicylate", "group", "77-86"], "DRUGB": ["corticosteroid", "group", "102-115"]}
{"ID": "DDI-DrugBank.d737.s10.p43", "TEXT1": "Dopamine antagonists: Since N/A is a N/A N/A it is N/A that N/A antagonists such as the N/A (phenothiazines N/A @DRUG$) or N/A may N/A the N/A of @DRUG$", "LBL": "DDI-effect", "DRUGA": ["thioxanthenes", "group", "163-175"], "DRUGB": ["MIRAPEX", "brand", "231-237"]}
{"ID": "DDI-DrugBank.d597.s4.p1", "TEXT1": "however as with other @DRUG$ N/A N/A of N/A and @DRUG$ is N/A generally N/A because of the N/A for N/A N/A N/A", "LBL": "DDI-advise", "DRUGA": ["NSAIDs", "group", "23-28"], "DRUGB": ["aspirin", "brand", "75-81"]}
{"ID": "DDI-DrugBank.d680.s1.p37", "TEXT1": "N/A on N/A N/A N/A N/A of N/A with other N/A N/A N/A N/A is N/A with N/A use of the following: @DRUG$ N/A N/A N/A N/A N/A (and its N/A N/A desmethyldiazepam) N/A N/A N/A N/A N/A N/A an N/A N/A (@DRUG$/ethinyl estradiol) N/A N/A N/A N/A N/A N/A N/A or N/A", "LBL": "0", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["levonorgestrel", "drug", "358-371"]}
{"ID": "DDI-DrugBank.d784.s4.p14", "TEXT1": "Other N/A of the N/A N/A N/A N/A N/A such as antimycotic N/A (e g N/A and @DRUG$) or N/A N/A (e g N/A and clarithromycin) may N/A @DRUG$ N/A N/A N/A (i e N/A and AUC)", "LBL": "DDI-mechanism", "DRUGA": ["miconazole", "drug", "110-119"], "DRUGB": ["oxybutynin", "drug", "198-207"]}
{"ID": "DDI-DrugBank.d677.s0.p4", "TEXT1": "@DRUG$ are N/A of potentiating N/A N/A (e g N/A N/A N/A @DRUG$ N/A )", "LBL": "DDI-effect", "DRUGA": ["Phenothiazines", "group", "0-13"], "DRUGB": ["alcohol", "drug", "102-108"]}
{"ID": "DDI-DrugBank.d697.s0.p7", "TEXT1": "N/A for N/A N/A (@DRUG$): N/A N/A N/A N/A @DRUG$ N/A N/A", "LBL": "DDI-int", "DRUGA": ["Thiamine", "drug", "29-36"], "DRUGB": ["Stavudine", "drug", "78-86"]}
{"ID": "DDI-DrugBank.d769.s2.p5", "TEXT1": "Other HDAC Inhibitors N/A N/A and N/A N/A have been N/A with N/A N/A N/A N/A and other @DRUG$ (e g @DRUG$)", "LBL": "0", "DRUGA": ["HDAC inhibitors", "group", "137-151"], "DRUGB": ["valproic acid", "drug", "160-172"]}
{"ID": "DDI-DrugBank.d726.s2.p0", "TEXT1": "N/A N/A of @DRUG$ N/A may be N/A and iPTH and N/A N/A N/A should be closely N/A if a N/A N/A or N/A N/A with a N/A N/A N/A such as @DRUG$", "LBL": "DDI-advise", "DRUGA": ["Zemplar", "brand", "19-25"], "DRUGB": ["ketoconazole", "drug", "209-220"]}
{"ID": "DDI-DrugBank.d680.s1.p134", "TEXT1": "N/A on N/A N/A N/A N/A of N/A with other N/A N/A N/A N/A is N/A with N/A use of the following: N/A N/A N/A N/A N/A @DRUG$ (and its N/A N/A desmethyldiazepam) N/A N/A N/A N/A @DRUG$ N/A an N/A N/A (levonorgestrel/ethinyl estradiol) N/A N/A N/A N/A N/A N/A N/A or N/A", "LBL": "0", "DRUGA": ["diazepam", "drug", "216-223"], "DRUGB": ["ethanol", "drug", "315-321"]}
{"ID": "DDI-DrugBank.d709.s3.p4", "TEXT1": "Although such a N/A has N/A been demonstrated with N/A N/A N/A of @DRUG$ with N/A or @DRUG$ is N/A N/A", "LBL": "DDI-advise", "DRUGA": ["roxithromycin", "drug", "101-113"], "DRUGB": ["astemizole", "drug", "135-144"]}
{"ID": "DDI-DrugBank.d638.s0.p0", "TEXT1": "@DRUG$ may N/A the N/A N/A of @DRUG$", "LBL": "DDI-effect", "DRUGA": ["Ritalin", "brand", "0-6"], "DRUGB": ["guanethidine", "drug", "47-58"]}
{"ID": "DDI-DrugBank.d695.s0.p0", "TEXT1": "While co administration of @DRUG$ N/A N/A N/A the N/A of @DRUG$ by 70% these N/A are N/A N/A because of the N/A N/A of N/A N/A and because N/A N/A N/A N/A of N/A", "LBL": "DDI-mechanism", "DRUGA": ["ZAVESCA", "brand", "27-33"], "DRUGB": ["Cerezyme", "brand", "76-83"]}
{"ID": "DDI-DrugBank.d655.s0.p9", "TEXT1": "@DRUG$ may interact with N/A (tricyclic type) N/A N/A (e g N/A N/A N/A N/A N/A furazolidone) @DRUG$ N/A N/A (e g diphenhydramine) other N/A N/A N/A N/A N/A N/A N/A anti diarrhea N/A (e g kaolin pectin) N/A (e g N/A promethazine)", "LBL": "DDI-int", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["quinidine", "drug", "172-180"]}
{"ID": "DDI-DrugBank.d781.s6.p19", "TEXT1": "N/A N/A potassium sparing diuretics (spironolactone N/A @DRUG$ and others) potassium supplements or other N/A N/A N/A N/A serum potassium (@DRUG$ N/A N/A and others) can N/A the N/A N/A N/A", "LBL": "0", "DRUGA": ["triamterene", "drug", "63-73"], "DRUGB": ["indomethacin", "drug", "164-175"]}
{"ID": "DDI-DrugBank.d775.s10.p18", "TEXT1": "Other N/A which may N/A the N/A N/A N/A of N/A N/A such as @DRUG$ N/A N/A N/A (e g N/A N/A @DRUG$ N/A N/A N/A N/A and N/A colistimethate) N/A N/A N/A N/A N/A N/A and N/A", "LBL": "DDI-int", "DRUGA": ["MIVACRON", "brand", "98-105"], "DRUGB": ["bacitracin", "drug", "174-183"]}
{"ID": "DDI-DrugBank.d628.s3.p2", "TEXT1": "During N/A of N/A or N/A the rate of @DRUG$ N/A N/A administration should be N/A N/A to the N/A N/A of N/A or N/A and may be N/A in the N/A of N/A N/A N/A (eg N/A N/A or @DRUG$)", "LBL": "DDI-advise", "DRUGA": ["DIPRIVAN", "brand", "58-65"], "DRUGB": ["opioids", "group", "268-274"]}
{"ID": "DDI-DrugBank.d776.s26.p0", "TEXT1": "A N/A N/A N/A that N/A @DRUG$ 200 mg N/A N/A and @DRUG$ 20 mg N/A N/A a N/A yielded a significant N/A in N/A N/A levels and N/A of N/A N/A", "LBL": "DDI-mechanism", "DRUGA": ["fluconazole", "drug", "42-52"], "DRUGB": ["cisapride", "drug", "76-84"]}
{"ID": "DDI-DrugBank.d675.s4.p4", "TEXT1": "Less N/A N/A N/A @DRUG$ N/A N/A N/A N/A N/A N/A @DRUG$ and N/A", "LBL": "0", "DRUGA": ["saquinavir", "drug", "31-40"], "DRUGB": ["zileuton", "drug", "111-118"]}
{"ID": "DDI-DrugBank.d652.s6.p0", "TEXT1": "Because the N/A of @DRUG$ will influence the N/A of N/A to the N/A and thus the N/A of N/A @DRUG$ N/A or N/A of N/A may require N/A", "LBL": "DDI-advise", "DRUGA": ["metoclopramide", "drug", "22-35"], "DRUGB": ["insulin", "drug", "124-130"]}
{"ID": "DDI-DrugBank.d703.s0.p14", "TEXT1": "N/A with Other Central Nervous System Depressants: @DRUG$ SHOULD BE N/A N/A N/A N/A AND IN N/A N/A IN N/A WHO ARE CONCURRENTLY N/A OTHER N/A N/A N/A N/A N/A OTHER N/A @DRUG$ (INCLUDING BARBITURATES) N/A N/A AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL)", "LBL": "DDI-advise", "DRUGA": ["MEPERIDINE", "drug", "59-68"], "DRUGB": ["SEDATIVE-HYPNOTICS", "group", "254-271"]}
{"ID": "DDI-MedLine.d180.s12.p0", "TEXT1": "In N/A @DRUG$ N/A might be N/A N/A N/A of Bcl 2 and the N/A of @DRUG$ and DZNep could synergistically N/A N/A", "LBL": "0", "DRUGA": ["DZNep", "drug_n", "13-17"], "DRUGB": ["ABT-737", "drug_n", "106-112"]}
{"ID": "DDI-DrugBank.d716.s0.p1", "TEXT1": "You cannot N/A @DRUG$ if you have N/A N/A N/A N/A N/A (@DRUG$) such as N/A (Marplan) N/A (Parnate) or N/A (Nardil) in the N/A 14 N/A", "LBL": "DDI-advise", "DRUGA": ["mazindol", "drug", "16-23"], "DRUGB": ["MAOI", "group", "74-77"]}
{"ID": "DDI-DrugBank.d720.s3.p25", "TEXT1": "Therefore the N/A N/A N/A N/A N/A in N/A N/A MAO A inhibitors is N/A Selective serotonin reuptake inhibitors (@DRUG$) (e g N/A N/A N/A sertraline) have been N/A N/A N/A N/A N/A N/A and N/A when coadministered with @DRUG$", "LBL": "DDI-effect", "DRUGA": ["SSRIs", "group", "153-157"], "DRUGB": ["sumatriptan", "drug", "322-332"]}
{"ID": "DDI-DrugBank.d774.s0.p1", "TEXT1": "@DRUG$ may interact with N/A or @DRUG$ (causing too N/A a N/A in adrenal function)", "LBL": "DDI-int", "DRUGA": ["Trilostane", "drug", "0-9"], "DRUGB": ["mitotane", "drug", "50-57"]}
{"ID": "DDI-DrugBank.d716.s0.p5", "TEXT1": "You cannot N/A @DRUG$ if you have N/A N/A N/A N/A N/A (MAOI) such as N/A (Marplan) N/A (@DRUG$) or N/A (Nardil) in the N/A 14 N/A", "LBL": "DDI-advise", "DRUGA": ["mazindol", "drug", "16-23"], "DRUGB": ["Parnate", "brand", "130-136"]}
{"ID": "DDI-DrugBank.d652.s1.p3", "TEXT1": "N/A N/A N/A can N/A when @DRUG$ is N/A with N/A N/A N/A @DRUG$ or N/A", "LBL": "DDI-effect", "DRUGA": ["metoclopramide", "drug", "41-54"], "DRUGB": ["narcotics", "group", "101-109"]}
{"ID": "DDI-DrugBank.d775.s10.p19", "TEXT1": "Other N/A which may N/A the N/A N/A N/A of N/A N/A such as @DRUG$ N/A N/A N/A (e g N/A N/A N/A @DRUG$ N/A N/A N/A and N/A colistimethate) N/A N/A N/A N/A N/A N/A and N/A", "LBL": "DDI-int", "DRUGA": ["MIVACRON", "brand", "98-105"], "DRUGB": ["polymyxins", "group", "186-195"]}
{"ID": "DDI-DrugBank.d666.s3.p0", "TEXT1": "@DRUG$ has been N/A N/A N/A N/A @DRUG$ N/A when both N/A are N/A N/A", "LBL": "DDI-mechanism", "DRUGA": ["Pindolol", "drug", "0-7"], "DRUGB": ["thioridazine", "drug", "42-53"]}
{"ID": "DDI-DrugBank.d739.s4.p4", "TEXT1": "N/A at Doses of N/A mg N/A N/A to N/A Steady State: did N/A significantly N/A the N/A N/A of either N/A of an oral @DRUG$ N/A norethindrone 1 mg/ethinyl @DRUG$ N/A N/A", "LBL": "0", "DRUGA": ["contraceptive", "group", "167-179"], "DRUGB": ["estradiol", "drug", "219-227"]}
{"ID": "DDI-DrugBank.d595.s1.p2", "TEXT1": "N/A and @DRUG$ are N/A with @DRUG$ solution", "LBL": "DDI-int", "DRUGA": ["dobutamine", "drug", "19-28"], "DRUGB": ["sodium bicarbonate", "drug", "52-69"]}
{"ID": "DDI-DrugBank.d775.s13.p66", "TEXT1": "Some N/A N/A are: N/A N/A N/A N/A N/A for N/A or high blood pressure N/A for N/A N/A N/A N/A N/A such as N/A or N/A N/A N/A N/A by N/A N/A N/A @DRUG$ N/A N/A or N/A N/A N/A such as @DRUG$ N/A N/A N/A or other N/A N/A", "LBL": "0", "DRUGA": ["neostigmine", "drug", "272-282"], "DRUGB": ["procaine", "drug", "340-347"]}
{"ID": "DDI-DrugBank.d633.s9.p7", "TEXT1": "When N/A or other N/A N/A N/A such as N/A and @DRUG$ have been N/A concurrently with @DRUG$ N/A N/A N/A N/A have been N/A", "LBL": "DDI-mechanism", "DRUGA": ["phenobarbital", "drug", "69-81"], "DRUGB": ["Mexitil", "brand", "117-123"]}
{"ID": "DDI-DrugBank.d597.s1.p0", "TEXT1": "This N/A should be N/A N/A in N/A N/A @DRUG$ concomitantly with @DRUG$", "LBL": "DDI-advise", "DRUGA": ["NSAIDs", "group", "66-71"], "DRUGB": ["ACE inhibitors", "group", "92-105"]}
{"ID": "DDI-DrugBank.d656.s3.p0", "TEXT1": "It is N/A that N/A @DRUG$ levels be N/A when N/A adjusting and N/A @DRUG$", "LBL": "DDI-advise", "DRUGA": ["lithium", "drug", "30-36"], "DRUGB": ["FELDENE", "brand", "103-109"]}
{"ID": "DDI-DrugBank.d775.s10.p24", "TEXT1": "Other N/A which may N/A the N/A N/A N/A of N/A N/A such as @DRUG$ N/A N/A N/A (e g N/A N/A N/A N/A N/A N/A N/A and N/A colistimethate) @DRUG$ salts N/A N/A N/A N/A and N/A", "LBL": "DDI-int", "DRUGA": ["MIVACRON", "brand", "98-105"], "DRUGB": ["magnesium", "group", "261-269"]}
{"ID": "DDI-MedLine.d204.s9.p0", "TEXT1": "Distinct and N/A N/A N/A was N/A between @DRUG$ and @DRUG$ by N/A N/A N/A when N/A with their N/A N/A", "LBL": "DDI-effect", "DRUGA": ["methylglyoxal", "drug_n", "70-82"], "DRUGB": ["piperacillin", "drug", "88-99"]}
{"ID": "DDI-DrugBank.d659.s4.p15", "TEXT1": "N/A has been N/A concurrently with N/A N/A N/A N/A @DRUG$ @DRUG$ N/A N/A and N/A without N/A N/A", "LBL": "0", "DRUGA": ["digitalis", "group", "79-87"], "DRUGB": ["diuretics", "group", "90-98"]}
{"ID": "DDI-DrugBank.d720.s3.p8", "TEXT1": "Therefore the N/A N/A N/A N/A N/A in N/A N/A @DRUG$ is N/A @DRUG$ (SSRIs) (e g N/A N/A N/A sertraline) have been N/A N/A N/A N/A N/A N/A and N/A when coadministered with N/A", "LBL": "0", "DRUGA": ["MAO-A inhibitors", "group", "74-89"], "DRUGB": ["Selective serotonin reuptake inhibitors", "group", "112-150"]}
{"ID": "DDI-DrugBank.d670.s7.p1", "TEXT1": "@DRUG$ may antagonize the N/A of N/A and other @DRUG$", "LBL": "DDI-effect", "DRUGA": ["Paliperidone", "drug", "0-11"], "DRUGB": ["dopamine agonists", "group", "61-77"]}
{"ID": "DDI-DrugBank.d716.s5.p47", "TEXT1": "Before N/A this N/A tell your N/A if you are N/A a N/A N/A such as N/A (Elavil) @DRUG$ (Asendin) N/A (@DRUG$) N/A (Pamelor) N/A (Tofranil) N/A (Anafranil) N/A (Vivactil) or N/A (Norpramin)", "LBL": "0", "DRUGA": ["amoxapine", "drug", "125-133"], "DRUGB": ["Sinequan", "brand", "155-162"]}
{"ID": "DDI-DrugBank.d585.s5.p0", "TEXT1": "@DRUG$ may antagonize the N/A N/A N/A that N/A N/A N/A such as @DRUG$", "LBL": "DDI-effect", "DRUGA": ["Anticholinergic drugs", "group", "0-20"], "DRUGB": ["metoclopramide", "drug", "104-117"]}
{"ID": "DDI-DrugBank.d636.s0.p0", "TEXT1": "Some @DRUG$ may interact with @DRUG$", "LBL": "DDI-int", "DRUGA": ["anticonvulsants", "group", "5-19"], "DRUGB": ["Mephenytoin", "drug", "39-49"]}
{"ID": "DDI-DrugBank.d598.s1.p1", "TEXT1": "@DRUG$ N/A at a N/A N/A N/A N/A the N/A half life by 51% and N/A the @DRUG$ N/A N/A N/A by 30%", "LBL": "DDI-mechanism", "DRUGA": ["Trimethoprim", "drug", "0-11"], "DRUGB": ["phenytoin", "drug", "108-116"]}
{"ID": "DDI-DrugBank.d661.s1.p0", "TEXT1": "If @DRUG$ is N/A N/A N/A of @DRUG$ it should N/A be N/A until N/A from N/A has been N/A", "LBL": "DDI-advise", "DRUGA": ["ZEMURON", "brand", "3-9"], "DRUGB": ["succinylcholine", "drug", "58-72"]}
{"ID": "DDI-DrugBank.d632.s3.p0", "TEXT1": "When the N/A N/A of a concomitant N/A N/A N/A is a N/A N/A of N/A (such as @DRUG$) the N/A should be N/A at least 1 N/A N/A N/A or N/A N/A after @DRUG$ N/A", "LBL": "DDI-advise", "DRUGA": ["analgesics", "group", "116-125"], "DRUGB": ["SYMLIN", "brand", "204-209"]}
{"ID": "DDI-DrugBank.d752.s10.p4", "TEXT1": "The N/A N/A of @DRUG$ is N/A by any concomitantly N/A N/A which depresses the N/A N/A N/A particularly N/A (eg N/A N/A and fentanyl) @DRUG$ N/A N/A N/A N/A and N/A", "LBL": "DDI-effect", "DRUGA": ["VERSED Syrup", "brand", "23-34"], "DRUGB": ["propofol", "drug", "204-211"]}
{"ID": "DDI-DrugBank.d604.s2.p1", "TEXT1": "Oral @DRUG$: In N/A N/A N/A the N/A N/A of N/A and @DRUG$ N/A N/A of a N/A N/A N/A 1 0 mg of N/A acetate and N/A N/A of N/A N/A were N/A", "LBL": "0", "DRUGA": ["Contraceptives", "group", "5-18"], "DRUGB": ["ethinyl estradiol", "drug", "92-108"]}
{"ID": "DDI-MedLine.d218.s9.p0", "TEXT1": "Also @DRUG$ which is N/A believed N/A interact with @DRUG$ N/A the N/A of N/A N/A (OR = N/A N/A [95% N/A N/A N/A 2 35])", "LBL": "DDI-effect", "DRUGA": ["mirtazapine", "drug", "5-15"], "DRUGB": ["warfarin", "drug", "57-64"]}
